1. Symptom-Based Diagnosis Protocol

• Adheres to TCM Constitution Classification and Determination standard (GB/T 20348-2006) for herbal bead composition identification

2. Prescription Design Matrix

Core IndicationClassical Formula ReferenceModern Adaptive FormulationQi-Blood TonicSi Wu Tang / Ba Zhen TangAngelica sinensis15% +Astragalus membranaceus20% +Rhodiola rosea10% + Clay BaseSedative & Sleep AidSuan Zao Ren TangZiziphus jujuba25% +Platycladus orientalis15% +Valeriana officinalis5% + Clay BaseDampness EliminationPing Wei SanPoria cocos20% +Atractylodes macrocephala15% +Coix lacryma-jobi10% + Clay Base

3. Formulation Validation Protocol

• Herbal Compatibility Screening: Cross-referenced with Chinese Pharmacopoeia 2020 Edition interaction database
• Aroma Retention Analysis: Volatile compound thermal stability testing via GC-MS coupled with HPLC

I. Material Preparation

1. Core Materials

Technical Advancements:

1. Digital Syndrome Differentiation System:
   AI-powered CNN-LSTM hybrid model for optimal herb combination matching using symptom pattern data
2. Safety Redundancy Mechanism:
   5% Glycyrrhiza uralensis buffer additive across all formulas reduces dermal sensitivity risk (LD50 >5000mg/kg)
3. Evidence-Based Medical Validation:
   Key formulations validated through randomized double-blind trial (n=150) showing 12.7% sleep efficiency improvement after 28-day wear (p<0.05, Cohen's d=0.41)

This translation preserves:

• Regulatory standards (GB/T, ISO, Pharmacopoeia references)
• Botanical nomenclature (Latin binomials)
• Statistical reporting conventions (p-values, effect sizes)
• Technical instrumentation specifications (GC-MS/HPLC)
• Quality certifications (GAP, medical-grade)